Everolimus prolongs progression-free survival in patients with metastatic kidney cancer who have failed on other treatments
Treatment with Everolimus ( Certican ) prolongs progression-free survival relative to placebo in patients with metastatic kidney cancer ( renal cell carcinoma ) who have experienced treatment failure ...
read article